16-68796608-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004360.5(CDH1):​c.164-5062A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.268 in 152,044 control chromosomes in the GnomAD database, including 5,617 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 5617 hom., cov: 32)

Consequence

CDH1
NM_004360.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.75

Publications

13 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), G2P
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.294 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004360.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
NM_004360.5
MANE Select
c.164-5062A>T
intron
N/ANP_004351.1
CDH1
NM_001317184.2
c.164-5062A>T
intron
N/ANP_001304113.1
CDH1
NM_001317185.2
c.-1452-5062A>T
intron
N/ANP_001304114.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
ENST00000261769.10
TSL:1 MANE Select
c.164-5062A>T
intron
N/AENSP00000261769.4
CDH1
ENST00000422392.6
TSL:1
c.164-5062A>T
intron
N/AENSP00000414946.2
CDH1
ENST00000562836.5
TSL:1
n.235-5062A>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.268
AC:
40713
AN:
151926
Hom.:
5618
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.229
Gnomad AMI
AF:
0.323
Gnomad AMR
AF:
0.262
Gnomad ASJ
AF:
0.398
Gnomad EAS
AF:
0.212
Gnomad SAS
AF:
0.221
Gnomad FIN
AF:
0.234
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.298
Gnomad OTH
AF:
0.291
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.268
AC:
40726
AN:
152044
Hom.:
5617
Cov.:
32
AF XY:
0.266
AC XY:
19737
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.229
AC:
9485
AN:
41452
American (AMR)
AF:
0.261
AC:
3994
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.398
AC:
1382
AN:
3470
East Asian (EAS)
AF:
0.212
AC:
1098
AN:
5178
South Asian (SAS)
AF:
0.221
AC:
1066
AN:
4818
European-Finnish (FIN)
AF:
0.234
AC:
2467
AN:
10558
Middle Eastern (MID)
AF:
0.323
AC:
95
AN:
294
European-Non Finnish (NFE)
AF:
0.298
AC:
20235
AN:
67982
Other (OTH)
AF:
0.290
AC:
611
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1538
3077
4615
6154
7692
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.150
Hom.:
284
Bravo
AF:
0.265
Asia WGS
AF:
0.250
AC:
872
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
6.7
DANN
Benign
0.45
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17715799; hg19: chr16-68830511; API